• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » China halts anti-dumping probe into EU, Japan dialysis kit makers

China halts anti-dumping probe into EU, Japan dialysis kit makers

December 17, 2014 By MassDevice Contributors Network

China halts anti-dumping probe into EU, Japan dialysis kit makers

(Reuters) — China halted an anti-dumping investigation into European and Japanese makers of blood dialysis equipment, ending a 6-month probe that had extended to the Chinese market leader, Germany’s Fresenius Medical Care (NYSE:FMS).

The investigation, launched in June, was a potential challenge to the international firms who currently dominate the global and Chinese dialysis market. Beijing said at the time it would examine any negative impact on Chinese rivals.

"The Ministry of Commerce will from today halt the anti-dumping investigation into hemodialysis devices imported from the European Union and Japan," the ministry said in a short statement on its website today.

The statement added that a local dialysis kit maker which had initially requested the investigation had asked for the case to be dropped earlier this month.

Foreign firms dominate China’s dialysis market, with around ¾ of the devices used in the country in 2012 imported, according to consultancy Research in China. The U.S., Europe and Japan are the major sources of supply.

An Fresenius spokesman said earlier this year that the firm, which controls close to half of the Chinese market for blood dialysis machines, had been part of the anti-dumping probe.

Kidney disease is a growing problem in China due to the country’s aging population. Around 120 million patients suffer chronic kidney disease in the country, according to a 2012 paper in medical journal The Lancet.

A smaller number of patients with severe forms of disease may require dialysis.

Officials at local Chinese firms previously told Reuters the probe could help break the hold of global rivals on the market.

FMC and its U.S. rival Baxter (NYSE:BAX), which owns Sweden-based dialysis kit maker Gambro, each hold around 30% of the global market.

Japanese firms, including Nikkiso (TYO:6376) and Nipro (TYO:8086), are the closest rivals to their U.S. and European counterparts.

Filed Under: Dialysis, News Well Tagged With: Baxter, Dialysis, Exports, Fresenius, Gambro, Nikkiso America, Nipro

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy